Chylothorax: A Stepwise Approach to Diagnosis and Treatment

Neonatal Netw. 2021 Nov 1;40(6):386-392. doi: 10.1891/11-T-705.

Abstract

Chylothorax, a lymphatic flow disorder characterized by an abnormal circulation of lymph fluid into the pleural cavity, is the most common cause of pleural effusions during the neonatal period. This condition affects 1/15,000 neonates every year. Affected neonates often manifest with respiratory distress, electrolyte imbalances, sepsis, and even immunodeficiencies. Mortality risk is highest among neonates undergoing cardiac surgery as well as those with associated hydrops fetalis. Conservative treatment options include bowel rest with administration of parenteral nutrition, followed with medium-chain triglyceride enteral feedings, and octreotide therapy. Severe or persistent cases require surgical intervention. This can involve a unilateral or bilateral pleurectomy and thoracic duct ligation, with or without pleurodesis. Early identification and successful treatment of this condition is contingent upon awareness of the most current evidence and a timely cross-disciplinary approach to care.

Keywords: chyle; lymphangiectasia; lymphatic; neonate; pleural effusion; respiratory.

MeSH terms

  • Chylothorax* / diagnosis
  • Chylothorax* / etiology
  • Chylothorax* / therapy
  • Humans
  • Hydrops Fetalis
  • Infant, Newborn
  • Ligation
  • Pleural Effusion*
  • Pleurodesis